Comen BL70 Infant Phototherapy Equipment
$836.55~1022.45 / Parcel$1338.48 Min.order:1
Certificated Products
High-intensity Phototherapy Efficient Jaundice Treatment According to statistics, clinically 80% of pre-term and 60% of full-term infants are at risk of hyperbilirubinemia. BL70 Infant Phototherapy Equipment helps cure jaundice safely and efficiently with superior technology and high-performance phototherapy.

Support Payment Term:

HSBC Hong Kong

paypal

Alibaba Pay

Western Union

USD

EUR

GBP

SGD

HKD

CNH

CAD

MXN

BRL

JPY

THB

MOP

AUD

NZD

PLN

CZK

HUF

RON

CHF

SEK

NOK

DKK

TRY

AED

SAR

ILS

ZAR

$0.00

Quantity

Discover similar items

Page 1 of 2

Ultra compact —- Lightweight and portable, taking up the least space.
Focus on Therapy,
Applicable to Various Settings

Large screen —- 4.3-inch color touch screen, easy to observe and operate.

Ultra quiet —- Fanless design, noise free, ensuring a quiet and comfort environment.

Trolley design —- Convenient to move, seamless integration of different settings,
including radiant warmer and baby cradle bed.

Quick-release structure —- The main unit can be quickly separated from the trolley
and placed directly on the incubator hood.

Flexible adjustment —- Easy adjustment of height and angle.

Comes with manual book, power cord, suction cup (4pcs) & stand

Warranty:1 year
MDA Reg No.: GB2860921-68528

According to statistics, clinically 80% of pre-term and 60% of full-term infants are at risk of hyperbilirubinemia.
BL70 Infant Phototherapy Equipment helps cure jaundice safely and efficiently with superior technology and high-performance phototherapy.
High-intensity irradiance
Equipped with high-intensity LED cold light source, with less heat production, BL70 supports long-time treatment.
With the maximal irradiance level of 63μW/cm²/nm, BL70 enhances the bilirubin breakdown ability and shortens the treatment time.
With five levels irradiance adjustment, BL70 allows treatment tailored to each patient’s needs.
Longer service life
The service life is up to 50,000 hours, ensuring clinical usage and minimizing the cost for the end users.
Optimal wavelength
The wavelength of the spectrum is 430 - 490 nm and has been shown by the American Academy of Pediatrics (AAP) to be the most effective in reducing unconjugated bilirubin; it also does not contain near-UV wavelengths that are harmful to the skin. These made it very suitable for the treatment of neonatal jaundice.
Uniform irradiance distribution
Our innovative optical design ensures uniform irradiance distribution, minimizes spill light and exposure, with LED light evenly covering the total body surface of the neonates to ensure the effect of phototherapy.
Precise Treatment for Neonatal Jaundice
Equipped with an irradiance probe to accurately measure the irradiance value and ensures that the baby receives enough irradiance, achieving precise treatment.
Irradiance probe
After clarification using irradiance probe, phototherapy irradiance value of 5 levels can be displayed on the screen.